MM: MM has received grants and honorarium from GSK and has received travel grants for presentations from GSK, Merck Sharp and Diagnostics, Novartis, Sanofi Pasteur and United Laboratories as well as payments for development of educational presentations from different organizations in the Philippines.
Dr Matharu serves on the advisory board for Allergan and St Jude Medical, and has received payment for the development of educational presentations from Allergan, Merck Sharpe and Dohme Ltd and Medtronic.
MSM serves on the advisory board for Allergan, St Jude Medical and Medtronic and has received payment for the development of educational presentations from Allergan, St Jude Medical, Medtronic and electroCore.
Dr. Prieto has received honoraria for speaker activities and development of educational presentations from GlaxoSmithKline, has received travel support from GlaxoSmithKline, Lilly, Lundbeck, and Pharmavita, has received research support from the Marriott Foundation and from Mayo Foundation for Medical Education and Research and has received scholarships from the Government of Chile.
TFS was paid for the development of educational presentations from the GSK group of companies.
J.A.C.S. has received payment for development of educational presentations from Gilead.
Anthony Strong was paid a consultancy fee, as well as receiving payment for development of educational presentations by Codman Johnson & Johnson.
EV has received lecture and consulting fees from Merck and has received payment for development of educational presentations from Merck.
C. Smith has a pending grant from Bristol-Myers Squibb and received payment for development of educational presentations by Gilead Sciences and ViiV Healthcare.
Finally, we hypothesized that peer victimization would place adolescents at risk for the development of complex presentations involving diagnostic comorbidity.
He has received payment for development of educational presentations from GlaxoSmithKline (GSK, Germany), Bencard (Germany), ALK-Abello (Germany/Denmark), Stallergenes (Germany/France), and Novartis (Germany).
